Role of MRI in Primary Rectal Cancer Staging and Management

Slides:



Advertisements
Similar presentations
PROF OF OB &GYN. AIN SHAMS UNIVERSITY,GYNEONCOLOGY UNIT.
Advertisements

Neoadjuvant therapy for Rectal cancer
Geraldine O’Dowd Consultant Pathologist NHS Lanarkshire 18 th November 2014 Colorectal Cancer Pathology: Impact of new guidelines for the laboratory.
Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.
Polyps – Where do they come from and what do you do with them?!
Endoscopic Ultrasound in Rectal Cancer Natasha Schneider November 15, 2010.
AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
T Staging: Rectal cancer T1 invades submucosa T2 invades muscularis propria T3 invades subserosa or perirectal tissues T4 invades peritoneum, organs or.
Total Mesorectal Excision A Practical Guide. Total Mesorectal Excision Background Original description in 1982 Complete excision of the mesorectum Meticulous.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
Pre-TME era. Mesorectal subsite/LN ALWAYS included in CTV Mesorectal subsite / LN region.
Mechanism of Action Combidex in MR Imaging Mukesh Harisinghani, MD Department of Radiology, Massachusetts General Hospital.
Impact of Lymph-Node Metastatic Site in Patients with Thoracic Esophageal Cancer Edited by: Kunisaki C., Makino H., Kimura J., Oshima T., Fujii S., Takagawa.
Bladder CA-Staging.
Colon Cancer Basic Science 9/21/05. Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
PROFESSOR PANKAJ G. JANI. M.MED., FRCS. DEPT. OF SURGERY, UNIVERSITY OF NAIROBI. KENYATTA NATIONAL HOSPITAL CHAIR. EXAMINATIONS AND CREDENTIALS COMMITTEE.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Treatment of Early Malignant Rectal Polyp
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Resection For Lung Metastases M62 Coloproctology Course.
Slides last updated: March 2015 CRC: STAGING. How colorectal cancer (CRC) is staged 1 Stage describes the extent of cancer, and is one of the most important.
Brendan Moran Basingstoke OCTOBER 2008
Role of EUS in colon lesions Pietro Fusaroli Gastroenterologia Università di Bologna.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
CR07 results and informed patient consent David Sebag-Montefiore Leeds Cancer Centre.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Preoperative chemoradiotherapy and postoperative chemotherapy with 5-FU and oxaliplatin versus 5-FU alone in locally advanced rectal cancer: First results.
Neoplasms of the bladder
RT with TME surgery ? OUTLINEOUTLINE. Prostate Seminal vessels Neurovascular bundle Denonvilliers Fascia “holy plane” (Fascia rectalis) Total Mesorectal.
Pathologist and Prognosis in Colorectal Cancer Surgery. Dr Bryan F Warren Consultant Gastrointestinal Pathologist Oxford M62 Course 2004.
Datum/Vortragsthema Local resection of Rectum tumors Peter M. Markus Elisabeth Hospital Essen Germany.
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
* AP: Anteroposterior, Lat: Lateral Tumor diameter, tumor length, depth of penetration, distance from the anal verge, deep and narrow pelvic dimension.
Local recurrence after rectal cancer resection is strongly related to the plane of surgical (PoS) dissection and is further reduced by pre-operative short.
T Staging: Rectal cancer T1 invades submucosa T2 invades muscularis propria T3 invades subserosa or perirectal tissues T4 invades peritoneum, organs or.
Adjuvant chemotherapy in Rectal Cancer?. What is the evidence for adjuvant chemotherapy? Do patients achieving a pathological complete response need chemotherapy?
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
TNM Staging: Colon and Rectum
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
11:40-12:00 Mandating structured reports Eric Loveday.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Rectal cancer staging go the full “DISTANCE” Geertje Noë.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Imaging Staging of colorectal cancer Wei-Chou Chang ( 張維洲 ) Associate Processor Department of Radiology, Tri-Service General Hospital and National Defense.
Extramural venous invasion in rectal cancer
Karcinom rektuma- management
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
Surgical Treatment in Locally Advanced Prostate Cancer
Magnetic Resonance Imaging of Anorectal Neoplasms
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
Dr Jessica Jenkins Consultant Oncologist
Effect of Neoadjuvant Concurrent Chemoradiotherapy on Locally Advanced Middle and Low Rectal Cancer— A Propensity Score Matching Study 官泰全,林春吉,楊純豪,姜正愷,林宏鑫,藍苑慈,
The STAR-TREC Trial SIV Presentation
Changes in TNM 8 To be used from
Developments in Colorectal Cancer
Presentation transcript:

Role of MRI in Primary Rectal Cancer Staging and Management Gerard Smith Austin Radiology

Overview Basic Epidemiology Basic Rectal Anatomy Key Anatomical Concepts The Role of MRI in Clinical Staging and its relevance to Treatment decisions

Rectal Cancer Statistics Jemal A, Siegal R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;50:225-249

Rectal Cancer Statistics Australia in 2005 13,076 new cases of colorectal carcinoma 13% of all cancer cases 4165 deaths Lifetime risk of 1 in 12 Rectal Cancer accounts for approx 1/3 of all colorectal cases TROG Cancer Research: trog.com.au

Anatomy of the Rectum Approximately 15 cm long Divided into lower, mid & upper thirds Lower: up to 5 cm from anal verge Lies below the peritoneal reflection Middle: 5 to 10 cm from anal verge Peritoneal reflection extends over the anterior surface Upper: 10 to 15 cm from anal verge Peritoneum covers the anterior and lateral aspects of rectum The mid to lower rectum is enveloped by the mesorectal fascia (MRF)

Mesorectal Fascia (MRF) Exists below the peritoneal reflection, extends to the pelvic floor and is an encircling fascia that contains: Rectum Perirectal fat Perirectal LN Perirectal vessels Variable in its definition Tapers distally Posteriorly it lays anterior to the presacral fascia

Total Mesorectal Excision (TME), and the Circumferential Resection Margin Surgical standard for rectal excision The rectum and the perirectal tissues en-bloc are excised The plane of the dissection is along the outer aspect of the MRF The Circumferential Resection Margin (CRM) is therefore in effect the MRF TME surgery has reduced local recurrence rates significantly (from 38% to 8%) Recurrence rates ? Dropped from approx 30% to ?8%

Total Mesorectal Excision

The Role of MRI To assist in clinical staging The treatment for rectal cancer is surgery (TME) with stage appropriate neoadjuvant therapy Intent of clinical staging is to identify patients suitable for upfront surgical resection neoadjuvant therapy followed by surgery Need accurate preoperative assessment Tumor (T) and Nodal (N) Stage Depth of tumor invasion beyond the muscle wall Relationship of the tumor to the MRF/CRM

Neoadjuvant Therapy Most commonly Chemoradiotherapy Short and Long course Radiotherapy Its addition in the treatment of locally advanced rectal carcinoma prior to TME has further reduced local recurrence rates from 8% to approximately 2% CRT is more effective, better tolerated, associated with better compliance and less toxicity when given as neoadjuvant therapy compared with post operatively ?low rectal site an indication for CRT

Anatomy of the Rectal Wall CIS T1 T2 Mucosa: thin hypointense line Submucosa: thicker band of high signal Muscularis propria: outer low signal intensity line T3

Staging of Rectal Carcinoma: TNM T Staging T1: Confined to the submucosa T2: Confined to the muscularis propria T3: Beyond the muscularis propria T4: Extension to involve Visceral peritoneum (T4a) Pelvic organs (T4b) such as prostate, seminal vesicles, cervix/uterus, bladder, pelvic side wall or pelvic floor.

T Staging of Rectal Carcinoma T1: Confined to Submucosa T2: Confined to Muscularis Propria

T Staging of Rectal Carcinoma T3: Beyond Muscularis Propria

T Staging of Rectal Carcinoma T4a: Involvement of Peritoneum

T Staging of Rectal Carcinoma T4b: Involvement of Pelvic Organs

T Staging of Rectal Carcinoma Difficult to depict T1 from early T2 on MRI Endorectal US plays a role MRI may overcall T2 tumors as early T3 Due to desmoplastic response in perirectal fat Perirectal extension should be called when the tumor margin within the perirectal fat is nodular and irregular and not low intensity linear spicules

T3 Staging of Rectal Carcinoma Majority (80%) of rectal cancers present as T3 tumors The degree of extension beyond the muscularis propria is important prognostically and potentially to the Rx chosen T3a <1mm T3b 1-5mm T3c >5-15mm T3d >15mm Early stage T3 (<5mm) 85% 5yr cancer specific survival Advanced stage T3 (>5mm) 54% 5yr cancer specific survival (Merkel et al. Int J Colorectal Dis 2001; 16: 298-304.)

MRI and histopathology were equivalent to within 0.5mm Prospectively assessed 295 patients who underwent primary TME surgery and compared the extramural depth of invasion on MRI to histopathology MRI and histopathology were equivalent to within 0.5mm Note was achieved by using standardized imaging techniques, pre study imaging and pathology workshops, and standardized imaging and pathology interpretation criteria Radiology 2007; 243: 132-139

Nodal staging N1 1-3 nodes N2 4 + nodes Regional LN are: perirectal, superior, middle and inferior rectal, sigmoid and inferior mesenteric, lateral sacral, sacral promontory, and internal iliac External Iliac and retroperitoneal LN are not regional but represent metastatic disease

Nodal staging Nodal staging on MRI is difficult Nodal size criteria of limited value Nodal morphology improves accuracy Irregular node contour Variable signal intensity Other techniques studied to improve accuracy include USPIO-enhanced MRI (Lahaye MJ, et al. Radiology 2008) Gadofosveset-enhanced MRI (Lambregts DM, et al. Abdominal Imaging 2012)

437 LN identified on pathology 42 TME specimens transversely sectioned and directly compared with MRI slices 437 LN identified on pathology 102 not seen on MRI because too small (<3mm) but only 2 of these contained metastases 51 above the area imaged and 7 of these contained metastases Size of benign and malignant LN similar Radiology 2003; 227(2): 371-377

Compared with using a 5mm cut-off When an irregular border or mixed signal intensity used for diagnosis Sensitivity 85% (95%CI 74% - 92%) Specificity 97% (95%CI 95% - 99%) Compared with using a 5mm cut-off Sensitivity 68% Specificity 78% Systematic Review and Meta-analysis (2000-2011) Lymph Node involvement Sensitivity 77% (95%CI 69%-84%) Specificity 71% (95%CI 59%-81%) Radiology 2003; 227(2): 371-377 Ann Surg Oncol 2012; 19:2212-2223

Mesorectal Fascial Involvement MRI is accurate in predicting an at risk CRM Tumor within 1 mm of the MRF is predictive of a positive CRM Advancing tumor margin Metastatic lymph node Malignant deposit Extramural Vascular Invasion (EMVI) Low rectal tumors are at greater risk of MRF involvement Identification of tumor involvement of the MRF modifies surgical approach

Extramural Vascular Invasion (EMVI) EMVI is the presence of tumor cells within blood vessels beyond the muscularis propria Present in 30-40% of specimens Associated with synchronous metastatic disease EMVI independently predicts local and distant recurrence and poorer overall survival

Retrospective study of 94 patients Sensitivity 62% Specificity 88% Relapse Free Survival at 3yrs 35% MRI-EVMI +ve 74% MRI-EVMI –ve British Journal of Surgery 2008; 95: 229-236

Summary Understanding of the key anatomical concepts of the MRF, CRM and TME surgery Understanding of the clinical staging of rectal cancer and the triage of patients to surgery alone or neoadjuvant CRT followed by surgery The limitations of Nodal staging and the importance of morphology over size Importance of assessing the tumor with respect to the MRF

Thank you